Cargando…

A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9

PURPOSE: AT04A and AT06A are two AFFITOPE® peptide vaccine candidates being developed for the treatment of hypercholesterolemia by inducing proprotein convertase subtilisin/kexin type 9 (PCSK9)-specific antibodies. This study aimed to investigate safety, tolerability, antibody development, and reduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeitlinger, Markus, Bauer, Martin, Reindl-Schwaighofer, Roman, Stoekenbroek, Robert M., Lambert, Gilles, Berger-Sieczkowski, Evelyn, Lagler, Heimo, Oesterreicher, Zoe, Wulkersdorfer, Beatrix, Lührs, Petra, Galabova, Gergana, Schwenke, Carsten, Mader, Robert M., Medori, Rossella, Landlinger, Christine, Kutzelnigg, Alexandra, Staffler, Günther
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440313/ https://www.ncbi.nlm.nih.gov/pubmed/33969434 http://dx.doi.org/10.1007/s00228-021-03149-2

Ejemplares similares

Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management
por: Galabova, Gergana, et al.
Publicado: (2014)

A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy
por: Meissner, Wassilios G., et al.
Publicado: (2020)

PCSK9 inhibition: the way forward in the treatment of dyslipidemia
por: Stoekenbroek, Robert M., et al.
Publicado: (2015)

The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
por: Landlinger, Christine, et al.
Publicado: (2017)

Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study
por: Poewe, Werner, et al.
Publicado: (2021)

Bacterial growth and ceftriaxone activity in individual ascitic fluids in an in vitro model of spontaneous bacterial peritonitis
por: van Os, Wisse, et al.
Publicado: (2023)

Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin
por: Oesterreicher, Zoe, et al.
Publicado: (2022)

Target site pharmacokinetics of doxycycline for rosacea in healthy volunteers is independent of the food effect
por: Pal, Arindam, et al.
Publicado: (2018)

Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?
por: Beilhack, Georg, et al.
Publicado: (2022)

Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave
por: Beilhack, Georg, et al.
Publicado: (2023)

Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer’s disease
por: Landlinger, Christine, et al.
Publicado: (2015)

Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography
por: Hernández Lozano, Irene, et al.
Publicado: (2019)

Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
por: Lemos, Miguel, et al.
Publicado: (2020)

Using Positron Emission Tomography to Study Transporter-Mediated Drug–Drug Interactions in Tissues
por: Wulkersdorfer, B, et al.
Publicado: (2014)

Infection with multidrug-resistant Campylobacter coli mimicking recurrence of carcinoid syndrome: a case report of a neuroendocrine tumor patient with repeated diarrhea
por: Lagler, Heimo, et al.
Publicado: (2016)

Effect of the human endotoxin challenge on tedizolid tissue penetration
por: Jorda, Anselm, et al.
Publicado: (2022)

Comparison of non-invasive Staphylococcus aureus sampling methods on lesional skin in patients with atopic dermatitis
por: Lagler, Heimo, et al.
Publicado: (2021)

Individual Prognosis Regarding Effectiveness of a Therapeutic Intervention Using Pre-Therapeutic “Kinesiology Muscle Test”
por: Waxenegger, Ingrid, et al.
Publicado: (2007)

ABO Blood Group. Related Investigations and Their Association with Defined Pathologies
por: Jesch, Ursula, et al.
Publicado: (2007)

Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants
por: Buitelaar, Jan, et al.
Publicado: (2009)

Formulation strategies in immunotherapeutic pharmaceutical products
por: Zhang, Yajie, et al.
Publicado: (2020)

Influence of Artificial Sweetener on Human Blood Glucose Concentration
por: Skokan, Ilse, et al.
Publicado: (2007)

Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens
por: Oesterreicher, Zoe, et al.
Publicado: (2017)

The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
por: Staufer, Katharina, et al.
Publicado: (2017)

A Longitudinal Seroprevalence Study Evaluating Infection Control and Prevention Strategies at a Large Tertiary Care Center with Low COVID-19 Incidence
por: Schubert, Lorenz, et al.
Publicado: (2021)

Immunotherapeutic Advancements for Glioblastoma
por: Ampie, Leonel, et al.
Publicado: (2015)

Editorial: Complement and Immunotherapeutics
por: Okrój, Marcin, et al.
Publicado: (2021)

Immunotherapeutic Advances for NSCLC
por: Massafra, Marco, et al.
Publicado: (2021)

Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography
por: Wulkersdorfer, Beatrix, et al.
Publicado: (2019)

PCSK9: The Nexus of Lipoprotein Metabolism and Inflammation in COVID-19
por: Goonewardena, Sascha N., et al.
Publicado: (2023)

Characterisation of inflammatory response, coagulation, and radiological findings in Katayama fever: a report of three cases at the Medical University of Vienna, Austria
por: Lagler, Heimo, et al.
Publicado: (2014)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2017)

Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies
por: Sartorius, Rossella, et al.
Publicado: (2019)

Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development
por: Galabova-Kovacs, Gergana, et al.
Publicado: (2008)

The Multifaceted Biology of PCSK9
por: Seidah, Nabil G, et al.
Publicado: (2021)

Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma
por: He, Mengni, et al.
Publicado: (2020)

Allergic mechanisms and immunotherapeutic strategies /
Publicado: (1997)

Immunotherapeutic Intervention against Sarcomas
por: Pedrazzoli, Paolo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_n1boh3um9vhr6305v9agu76mff